Deferred Income Tax Expense (Benefit) of SANGAMO THERAPEUTICS, INC from 31 Mar 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
SANGAMO THERAPEUTICS, INC quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2015 to 31 Mar 2025.
  • SANGAMO THERAPEUTICS, INC Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $15,000.
  • SANGAMO THERAPEUTICS, INC annual Deferred Income Tax Expense (Benefit) for 2024 was $0.
  • SANGAMO THERAPEUTICS, INC annual Deferred Income Tax Expense (Benefit) for 2023 was $6,335,000.
  • SANGAMO THERAPEUTICS, INC annual Deferred Income Tax Expense (Benefit) for 2022 was $0.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $15,000 +$15,000 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2015 $748,000 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1

SANGAMO THERAPEUTICS, INC Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 +$6,335,000 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $6,335,000 -$6,335,000 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2016 $14,000 +$5,708,000 +100% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $5,722,000 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.